[Treatment of acute urine retention caused by benign prostatic hypertrophy with an LH-RH agonist (Goserelin)].
Nineteen patients seen for AUR secondary to benign prostate hypertrophy and with high surgical risk, were treated with an LH-RH agonist (GOSERELIN). After six months of treatment a 43.28% decrease in the prostate volume was seen, Improvement, i.e., spontaneous miction, was achieved in 46.6% patients, although post-mictional volumes remained high.
Puyol Pallas
M
M
Servicio de Urología, Hospital San Juan de Dios, Martorell, Barcelona.
Gómez Parada
J
J
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D016055:Urinary Retention / Q000188:drug therapy* / Q000209:etiology
D017273:Goserelin